| 7-Nitroindazole | The risk or severity of adverse effects can be increased when 7-Nitroindazole is combined with Zimelidine. | Experimental |
| 7,8-DICHLORO-1,2,3,4-TETRAHYDROISOQUINOLINE | 7,8-DICHLORO-1,2,3,4-TETRAHYDROISOQUINOLINE may increase the serotonergic activities of Zimelidine. | Experimental |
| Acarbose | Zimelidine may increase the hypoglycemic activities of Acarbose. | Approved, Investigational |
| Acebutolol | The serum concentration of Acebutolol can be increased when it is combined with Zimelidine. | Approved |
| Acenocoumarol | Zimelidine may increase the anticoagulant activities of Acenocoumarol. | Approved |
| Acepromazine | The risk or severity of adverse effects can be increased when Acepromazine is combined with Zimelidine. | Approved, Vet Approved |
| Aceprometazine | The risk or severity of adverse effects can be increased when Aceprometazine is combined with Zimelidine. | Approved |
| Acetaminophen | The serum concentration of Acetaminophen can be increased when it is combined with Zimelidine. | Approved |
| Acetylsalicylic acid | Zimelidine may increase the antiplatelet activities of Acetylsalicylic acid. | Approved, Vet Approved |
| Adipiplon | The risk or severity of adverse effects can be increased when adipiplon is combined with Zimelidine. | Investigational |
| Afatinib | The serum concentration of Afatinib can be increased when it is combined with Zimelidine. | Approved |
| Agomelatine | The risk or severity of adverse effects can be increased when Agomelatine is combined with Zimelidine. | Approved, Investigational |
| Albiglutide | Zimelidine may increase the hypoglycemic activities of Albiglutide. | Approved |
| Aldosterone | The serum concentration of Aldosterone can be increased when it is combined with Zimelidine. | Experimental |
| Alfaxalone | The risk or severity of adverse effects can be increased when Alfaxalone is combined with Zimelidine. | Vet Approved |
| Alfentanil | Alfentanil may increase the serotonergic activities of Zimelidine. | Approved, Illicit |
| Alimemazine | The risk or severity of adverse effects can be increased when Alimemazine is combined with Zimelidine. | Approved, Vet Approved |
| Alitretinoin | The serum concentration of Alitretinoin can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Allopregnanolone | The risk or severity of adverse effects can be increased when Sage 547 is combined with Zimelidine. | Investigational |
| Alogliptin | Zimelidine may increase the hypoglycemic activities of Alogliptin. | Approved |
| Alphacetylmethadol | Alphacetylmethadol may increase the serotonergic activities of Zimelidine. | Experimental, Illicit |
| Alprazolam | The risk or severity of adverse effects can be increased when Alprazolam is combined with Zimelidine. | Approved, Illicit, Investigational |
| Alprenolol | The serum concentration of Alprenolol can be increased when it is combined with Zimelidine. | Approved, Withdrawn |
| Ambrisentan | The serum concentration of Ambrisentan can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Amisulpride | The risk or severity of adverse effects can be increased when Amisulpride is combined with Zimelidine. | Approved, Investigational |
| Amitriptyline | The serum concentration of Amitriptyline can be increased when it is combined with Zimelidine. | Approved |
| Amobarbital | The risk or severity of adverse effects can be increased when Amobarbital is combined with Zimelidine. | Approved, Illicit |
| Amoxapine | Zimelidine may increase the serotonergic activities of Amoxapine. | Approved |
| Amperozide | The risk or severity of adverse effects can be increased when Amperozide is combined with Zimelidine. | Experimental |
| Apixaban | The serum concentration of Apixaban can be increased when it is combined with Zimelidine. | Approved |
| Aripiprazole | The risk or severity of adverse effects can be increased when Aripiprazole is combined with Zimelidine. | Approved, Investigational |
| Arotinolol | The serum concentration of Arotinolol can be increased when it is combined with Zimelidine. | Approved |
| Arsenic trioxide | The serum concentration of Arsenic trioxide can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Articaine | The risk or severity of adverse effects can be increased when Articaine is combined with Zimelidine. | Approved |
| Asenapine | The risk or severity of adverse effects can be increased when Asenapine is combined with Zimelidine. | Approved |
| Atazanavir | The serum concentration of Atazanavir can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Atenolol | The serum concentration of Atenolol can be increased when it is combined with Zimelidine. | Approved |
| Axitinib | The serum concentration of Axitinib can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Azelastine | The risk or severity of adverse effects can be increased when Azelastine is combined with Zimelidine. | Approved |
| Baclofen | The risk or severity of adverse effects can be increased when Baclofen is combined with Zimelidine. | Approved |
| Barbital | The risk or severity of adverse effects can be increased when Barbital is combined with Zimelidine. | Illicit |
| Befunolol | The serum concentration of Befunolol can be increased when it is combined with Zimelidine. | Experimental |
| Bendroflumethiazide | Zimelidine may increase the hyponatremic activities of Bendroflumethiazide. | Approved |
| Benmoxin | Benmoxin may increase the serotonergic activities of Zimelidine. | Withdrawn |
| Benperidol | The risk or severity of adverse effects can be increased when Benperidol is combined with Zimelidine. | Investigational |
| Benzocaine | The risk or severity of adverse effects can be increased when Benzocaine is combined with Zimelidine. | Approved |
| Benzyl alcohol | The risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Zimelidine. | Approved |
| Betamethasone | The serum concentration of Betamethasone can be increased when it is combined with Zimelidine. | Approved, Vet Approved |
| Betaxolol | The serum concentration of Betaxolol can be increased when it is combined with Zimelidine. | Approved |
| Bevantolol | The serum concentration of Bevantolol can be increased when it is combined with Zimelidine. | Approved |
| Bezitramide | Bezitramide may increase the serotonergic activities of Zimelidine. | Experimental, Illicit, Withdrawn |
| Bisoprolol | The serum concentration of Bisoprolol can be increased when it is combined with Zimelidine. | Approved |
| BL-1020 | The risk or severity of adverse effects can be increased when BL-1020 is combined with Zimelidine. | Investigational |
| Boceprevir | The serum concentration of Boceprevir can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Bopindolol | The serum concentration of Bopindolol can be increased when it is combined with Zimelidine. | Approved |
| Bosutinib | The serum concentration of Bosutinib can be increased when it is combined with Zimelidine. | Approved |
| Brentuximab vedotin | The serum concentration of Brentuximab vedotin can be increased when it is combined with Zimelidine. | Approved |
| Brexpiprazole | The risk or severity of adverse effects can be increased when Brexpiprazole is combined with Zimelidine. | Approved |
| Brimonidine | The risk or severity of adverse effects can be increased when Brimonidine is combined with Zimelidine. | Approved |
| Bromazepam | The risk or severity of adverse effects can be increased when Bromazepam is combined with Zimelidine. | Approved, Illicit |
| Bromocriptine | The serum concentration of Bromocriptine can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Brompheniramine | The risk or severity of adverse effects can be increased when Brompheniramine is combined with Zimelidine. | Approved |
| Brotizolam | The risk or severity of adverse effects can be increased when Brotizolam is combined with Zimelidine. | Approved, Withdrawn |
| Bucindolol | The serum concentration of Bucindolol can be increased when it is combined with Zimelidine. | Investigational |
| Bufuralol | The serum concentration of Bufuralol can be increased when it is combined with Zimelidine. | Experimental, Investigational |
| Bupivacaine | The risk or severity of adverse effects can be increased when Bupivacaine is combined with Zimelidine. | Approved, Investigational |
| Bupranolol | The serum concentration of Bupranolol can be increased when it is combined with Zimelidine. | Approved |
| Buprenorphine | Buprenorphine may increase the serotonergic activities of Zimelidine. | Approved, Illicit, Investigational, Vet Approved |
| Buspirone | Buspirone may increase the serotonergic activities of Zimelidine. | Approved, Investigational |
| Butabarbital | The risk or severity of adverse effects can be increased when Butabarbital is combined with Zimelidine. | Approved, Illicit |
| Butalbital | The risk or severity of adverse effects can be increased when Butalbital is combined with Zimelidine. | Approved, Illicit |
| Butethal | The risk or severity of adverse effects can be increased when Butethal is combined with Zimelidine. | Approved, Illicit |
| Butorphanol | Butorphanol may increase the serotonergic activities of Zimelidine. | Approved, Illicit, Vet Approved |
| Cabazitaxel | The serum concentration of Cabazitaxel can be increased when it is combined with Zimelidine. | Approved |
| Caffeine | The serum concentration of Caffeine can be increased when it is combined with Zimelidine. | Approved |
| Camptothecin | The serum concentration of Camptothecin can be increased when it is combined with Zimelidine. | Experimental |
| Canagliflozin | The serum concentration of Canagliflozin can be increased when it is combined with Zimelidine. | Approved |
| Carbamazepine | The metabolism of Carbamazepine can be decreased when combined with Zimelidine. | Approved, Investigational |
| Carbinoxamine | The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Zimelidine. | Approved |
| Carfentanil | Carfentanil may increase the serotonergic activities of Zimelidine. | Illicit, Vet Approved |
| Carfilzomib | The serum concentration of Carfilzomib can be increased when it is combined with Zimelidine. | Approved |
| Carisoprodol | The risk or severity of adverse effects can be increased when Carisoprodol is combined with Zimelidine. | Approved |
| Caroxazone | Caroxazone may increase the serotonergic activities of Zimelidine. | Withdrawn |
| Carteolol | The serum concentration of Carteolol can be increased when it is combined with Zimelidine. | Approved |
| Carvedilol | The serum concentration of Carvedilol can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Celecoxib | Zimelidine may increase the antiplatelet activities of Celecoxib. | Approved, Investigational |
| Celiprolol | The serum concentration of Celiprolol can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Ceritinib | The serum concentration of Ceritinib can be increased when it is combined with Zimelidine. | Approved |
| Cerivastatin | The serum concentration of Cerivastatin can be increased when it is combined with Zimelidine. | Withdrawn |
| Cetirizine | The risk or severity of adverse effects can be increased when Cetirizine is combined with Zimelidine. | Approved |
| Chloral hydrate | The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Zimelidine. | Approved, Illicit, Vet Approved |
| Chlordiazepoxide | The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Zimelidine. | Approved, Illicit |
| Chlormezanone | The risk or severity of adverse effects can be increased when Chlormezanone is combined with Zimelidine. | Approved, Withdrawn |
| Chloroprocaine | The risk or severity of adverse effects can be increased when Chloroprocaine is combined with Zimelidine. | Approved |
| Chlorothiazide | Zimelidine may increase the hyponatremic activities of Chlorothiazide. | Approved, Vet Approved |
| Chlorphenamine | The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Zimelidine. | Approved |
| Chlorpromazine | The serum concentration of Chlorpromazine can be increased when it is combined with Zimelidine. | Approved, Vet Approved |
| Chlorpropamide | Zimelidine may increase the hypoglycemic activities of Chlorpropamide. | Approved |
| Chlorprothixene | The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Zimelidine. | Approved, Withdrawn |
| Chlorthalidone | Zimelidine may increase the hyponatremic activities of Chlorthalidone. | Approved |
| Chlorzoxazone | The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Zimelidine. | Approved |
| Cimetidine | The metabolism of Zimelidine can be decreased when combined with Cimetidine. | Approved |
| Cinchocaine | The risk or severity of adverse effects can be increased when Cinchocaine is combined with Zimelidine. | Approved, Vet Approved |
| Ciprofloxacin | The serum concentration of Ciprofloxacin can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Cisplatin | The serum concentration of Cisplatin can be increased when it is combined with Zimelidine. | Approved |
| Citalopram | Citalopram may increase the serotonergic activities of Zimelidine. | Approved |
| Clarithromycin | The serum concentration of Clarithromycin can be increased when it is combined with Zimelidine. | Approved |
| Clemastine | The risk or severity of adverse effects can be increased when Clemastine is combined with Zimelidine. | Approved |
| Clidinium | The risk or severity of adverse effects can be increased when Clidinium is combined with Zimelidine. | Approved |
| Clobazam | The serum concentration of Clobazam can be increased when it is combined with Zimelidine. | Approved, Illicit |
| Clomifene | The serum concentration of Clomifene can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Clomipramine | Zimelidine may increase the serotonergic activities of Clomipramine. | Approved, Vet Approved |
| Clonazepam | The risk or severity of adverse effects can be increased when Clonazepam is combined with Zimelidine. | Approved, Illicit |
| Clonidine | The serum concentration of Clonidine can be increased when it is combined with Zimelidine. | Approved |
| Clopidogrel | The serum concentration of Clopidogrel can be increased when it is combined with Zimelidine. | Approved, Nutraceutical |
| Clorazepate | The risk or severity of adverse effects can be increased when Clorazepate is combined with Zimelidine. | Approved, Illicit |
| Clozapine | The serum concentration of Clozapine can be increased when it is combined with Zimelidine. | Approved |
| Cobimetinib | The serum concentration of Cobimetinib can be increased when it is combined with Zimelidine. | Approved |
| Cocaine | The risk or severity of adverse effects can be increased when Cocaine is combined with Zimelidine. | Approved, Illicit |
| Codeine | Codeine may increase the serotonergic activities of Zimelidine. | Approved, Illicit |
| Colchicine | The serum concentration of Colchicine can be increased when it is combined with Zimelidine. | Approved |
| Conjugated estrogens | The serum concentration of Conjugated Equine Estrogens can be increased when it is combined with Zimelidine. | Approved |
| Crizotinib | The serum concentration of Crizotinib can be increased when it is combined with Zimelidine. | Approved |
| Cyclizine | The risk or severity of adverse effects can be increased when Cyclizine is combined with Zimelidine. | Approved |
| Cyclobenzaprine | The risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Zimelidine. | Approved |
| Cyclosporine | The serum concentration of Cyclosporine can be increased when it is combined with Zimelidine. | Approved, Investigational, Vet Approved |
| Cyproheptadine | The therapeutic efficacy of Zimelidine can be decreased when used in combination with Cyproheptadine. | Approved |
| Dabigatran etexilate | The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Zimelidine. | Approved |
| Dabrafenib | The serum concentration of Dabrafenib can be increased when it is combined with Zimelidine. | Approved |
| Dactinomycin | The serum concentration of Dactinomycin can be increased when it is combined with Zimelidine. | Approved |
| Dantrolene | The risk or severity of adverse effects can be increased when Dantrolene is combined with Zimelidine. | Approved |
| Dapagliflozin | The serum concentration of Dapagliflozin can be increased when it is combined with Zimelidine. | Approved |
| Dapiprazole | The risk or severity of adverse effects can be increased when Dapiprazole is combined with Zimelidine. | Approved |
| Dapoxetine | Dapoxetine may increase the serotonergic activities of Zimelidine. | Investigational |
| Dasatinib | The serum concentration of Dasatinib can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Daunorubicin | The serum concentration of Daunorubicin can be increased when it is combined with Zimelidine. | Approved |
| Debrisoquin | The serum concentration of Debrisoquin can be increased when it is combined with Zimelidine. | Approved |
| Deramciclane | The risk or severity of adverse effects can be increased when deramciclane is combined with Zimelidine. | Investigational |
| Desflurane | The risk or severity of adverse effects can be increased when Desflurane is combined with Zimelidine. | Approved |
| Desipramine | The risk or severity of adverse effects can be increased when Desipramine is combined with Zimelidine. | Approved |
| Desloratadine | The risk or severity of adverse effects can be increased when Desloratadine is combined with Zimelidine. | Approved, Investigational |
| Desmopressin | The risk or severity of adverse effects can be increased when Zimelidine is combined with Desmopressin. | Approved |
| Desvenlafaxine | Desvenlafaxine may increase the serotonergic activities of Zimelidine. | Approved |
| Dexamethasone | The serum concentration of Dexamethasone can be increased when it is combined with Zimelidine. | Approved, Investigational, Vet Approved |
| Dexbrompheniramine | The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Zimelidine. | Approved |
| Dexmedetomidine | The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Zimelidine. | Approved, Vet Approved |
| Dextromethorphan | Zimelidine may increase the serotonergic activities of Dextromethorphan. | Approved |
| Dextromoramide | Dextromoramide may increase the serotonergic activities of Zimelidine. | Experimental, Illicit |
| Dextropropoxyphene | Dextropropoxyphene may increase the serotonergic activities of Zimelidine. | Approved, Illicit, Withdrawn |
| Dezocine | Dezocine may increase the serotonergic activities of Zimelidine. | Approved |
| Diazepam | The serum concentration of Diazepam can be increased when it is combined with Zimelidine. | Approved, Illicit, Vet Approved |
| Dicoumarol | Zimelidine may increase the anticoagulant activities of Dicoumarol. | Approved |
| Diethylstilbestrol | The serum concentration of Diethylstilbestrol can be increased when it is combined with Zimelidine. | Approved |
| Difenoxin | The risk or severity of adverse effects can be increased when Difenoxin is combined with Zimelidine. | Approved, Illicit |
| Digitoxin | The serum concentration of Digitoxin can be increased when it is combined with Zimelidine. | Approved |
| Digoxin | The serum concentration of Digoxin can be increased when it is combined with Zimelidine. | Approved |
| Dihydrocodeine | Dihydrocodeine may increase the serotonergic activities of Zimelidine. | Approved, Illicit |
| Dihydroetorphine | Dihydroetorphine may increase the serotonergic activities of Zimelidine. | Experimental, Illicit |
| Dihydromorphine | Dihydromorphine may increase the serotonergic activities of Zimelidine. | Experimental, Illicit |
| Dihydrotestosterone | The serum concentration of Dihydrotestosterone can be increased when it is combined with Zimelidine. | Illicit |
| Diltiazem | The serum concentration of Diltiazem can be increased when it is combined with Zimelidine. | Approved |
| Dimenhydrinate | The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Zimelidine. | Approved |
| Diphenhydramine | The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Zimelidine. | Approved |
| Diphenoxylate | Diphenoxylate may increase the serotonergic activities of Zimelidine. | Approved, Illicit |
| Dipyridamole | The serum concentration of Dipyridamole can be increased when it is combined with Zimelidine. | Approved |
| Disopyramide | Zimelidine may increase the hypoglycemic activities of Disopyramide. | Approved |
| Docetaxel | The serum concentration of Docetaxel can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Domperidone | The serum concentration of Domperidone can be increased when it is combined with Zimelidine. | Approved, Investigational, Vet Approved |
| Dosulepin | The serum concentration of Dosulepin can be increased when it is combined with Zimelidine. | Approved |
| Doxepin | The risk or severity of adverse effects can be increased when Doxepin is combined with Zimelidine. | Approved |
| Doxorubicin | The serum concentration of Doxorubicin can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Doxylamine | The risk or severity of adverse effects can be increased when Doxylamine is combined with Zimelidine. | Approved, Vet Approved |
| Droperidol | The risk or severity of adverse effects can be increased when Droperidol is combined with Zimelidine. | Approved, Vet Approved |
| Drotebanol | The risk or severity of adverse effects can be increased when Drotebanol is combined with Zimelidine. | Experimental, Illicit |
| Dulaglutide | Zimelidine may increase the hypoglycemic activities of Dulaglutide. | Approved |
| Duloxetine | Duloxetine may increase the serotonergic activities of Zimelidine. | Approved |
| Dyclonine | The risk or severity of adverse effects can be increased when Dyclonine is combined with Zimelidine. | Approved |
| Ecgonine | The risk or severity of adverse effects can be increased when Ecgonine is combined with Zimelidine. | Experimental, Illicit |
| Ecopipam | The risk or severity of adverse effects can be increased when Ecopipam is combined with Zimelidine. | Investigational |
| Edoxaban | The serum concentration of Edoxaban can be increased when it is combined with Zimelidine. | Approved |
| Efavirenz | The risk or severity of adverse effects can be increased when Efavirenz is combined with Zimelidine. | Approved, Investigational |
| Eletriptan | The serum concentration of Eletriptan can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Eltanolone | The risk or severity of adverse effects can be increased when Pregnanolone is combined with Zimelidine. | Investigational |
| Empagliflozin | Zimelidine may increase the hypoglycemic activities of Empagliflozin. | Approved |
| Enflurane | The risk or severity of adverse effects can be increased when Enflurane is combined with Zimelidine. | Approved, Vet Approved |
| Entacapone | The risk or severity of adverse effects can be increased when Entacapone is combined with Zimelidine. | Approved, Investigational |
| Epinastine | The serum concentration of Epinastine can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Erlotinib | The serum concentration of Erlotinib can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Erythromycin | The serum concentration of Erythromycin can be increased when it is combined with Zimelidine. | Approved, Vet Approved |
| Escitalopram | Escitalopram may increase the serotonergic activities of Zimelidine. | Approved, Investigational |
| Esmolol | The serum concentration of Esmolol can be increased when it is combined with Zimelidine. | Approved |
| Estazolam | The risk or severity of adverse effects can be increased when Estazolam is combined with Zimelidine. | Approved, Illicit |
| Estradiol | The serum concentration of Estradiol can be increased when it is combined with Zimelidine. | Approved, Investigational, Vet Approved |
| Estriol | The serum concentration of Estriol can be increased when it is combined with Zimelidine. | Approved, Vet Approved |
| Estrone | The serum concentration of Estrone can be increased when it is combined with Zimelidine. | Approved |
| Eszopiclone | The risk or severity of adverse effects can be increased when Eszopiclone is combined with Zimelidine. | Approved |
| Ethanol | The risk or severity of adverse effects can be increased when Ethanol is combined with Zimelidine. | Approved |
| Ethchlorvynol | The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Zimelidine. | Approved, Illicit, Withdrawn |
| Ethinyl Estradiol | The serum concentration of Ethinyl Estradiol can be increased when it is combined with Zimelidine. | Approved |
| Ethosuximide | The risk or severity of adverse effects can be increased when Ethosuximide is combined with Zimelidine. | Approved |
| Ethotoin | The risk or severity of adverse effects can be increased when Ethotoin is combined with Zimelidine. | Approved |
| Ethyl biscoumacetate | Zimelidine may increase the anticoagulant activities of Ethyl biscoumacetate. | Withdrawn |
| Ethyl carbamate | The risk or severity of adverse effects can be increased when Ethyl carbamate is combined with Zimelidine. | Withdrawn |
| Ethyl loflazepate | The risk or severity of adverse effects can be increased when Ethyl loflazepate is combined with Zimelidine. | Approved, Illicit |
| Ethylmorphine | Ethylmorphine may increase the serotonergic activities of Zimelidine. | Approved, Illicit |
| Etidocaine | The risk or severity of adverse effects can be increased when Etidocaine is combined with Zimelidine. | Approved |
| Etifoxine | The risk or severity of adverse effects can be increased when Etifoxine is combined with Zimelidine. | Withdrawn |
| Etizolam | The risk or severity of adverse effects can be increased when Etizolam is combined with Zimelidine. | Approved |
| Etodolac | Zimelidine may increase the antiplatelet activities of Etodolac. | Approved, Investigational, Vet Approved |
| Etomidate | The risk or severity of adverse effects can be increased when Etomidate is combined with Zimelidine. | Approved |
| Etoperidone | Zimelidine may increase the serotonergic activities of Etoperidone. | Approved |
| Etoposide | The serum concentration of Etoposide can be increased when it is combined with Zimelidine. | Approved |
| Etoricoxib | Zimelidine may increase the antiplatelet activities of Etoricoxib. | Approved, Investigational |
| Etorphine | Etorphine may increase the serotonergic activities of Zimelidine. | Illicit, Vet Approved |
| Everolimus | The serum concentration of Everolimus can be increased when it is combined with Zimelidine. | Approved |
| Exenatide | Zimelidine may increase the hypoglycemic activities of Exenatide. | Approved, Investigational |
| Ezetimibe | The serum concentration of Ezetimibe can be increased when it is combined with Zimelidine. | Approved |
| Ezogabine | The risk or severity of adverse effects can be increased when Ezogabine is combined with Zimelidine. | Approved |
| Felbamate | The risk or severity of adverse effects can be increased when Felbamate is combined with Zimelidine. | Approved |
| Fencamfamine | The risk or severity of adverse effects can be increased when Fencamfamine is combined with Zimelidine. | Approved, Illicit, Withdrawn |
| Fenfluramine | Zimelidine may increase the serotonergic activities of Fenfluramine. | Illicit, Withdrawn |
| Fentanyl | Fentanyl may increase the serotonergic activities of Zimelidine. | Approved, Illicit, Investigational, Vet Approved |
| Fesoterodine | The serum concentration of Fesoterodine can be increased when it is combined with Zimelidine. | Approved |
| Fexofenadine | The serum concentration of Fexofenadine can be increased when it is combined with Zimelidine. | Approved |
| Fidaxomicin | The serum concentration of Fidaxomicin can be increased when it is combined with Zimelidine. | Approved |
| Flibanserin | The risk or severity of adverse effects can be increased when Flibanserin is combined with Zimelidine. | Approved |
| Fludiazepam | The risk or severity of adverse effects can be increased when Fludiazepam is combined with Zimelidine. | Approved, Illicit |
| Fluindione | Zimelidine may increase the anticoagulant activities of Fluindione. | Investigational |
| Flunarizine | The risk or severity of adverse effects can be increased when Flunarizine is combined with Zimelidine. | Approved |
| Flunitrazepam | The risk or severity of adverse effects can be increased when Flunitrazepam is combined with Zimelidine. | Approved, Illicit |
| Fluoxetine | Fluoxetine may increase the serotonergic activities of Zimelidine. | Approved, Vet Approved |
| Flupentixol | The risk or severity of adverse effects can be increased when Flupentixol is combined with Zimelidine. | Approved, Withdrawn |
| Fluphenazine | The risk or severity of adverse effects can be increased when Fluphenazine is combined with Zimelidine. | Approved |
| Flurazepam | The risk or severity of adverse effects can be increased when Flurazepam is combined with Zimelidine. | Approved, Illicit |
| Fluspirilene | The risk or severity of adverse effects can be increased when Fluspirilene is combined with Zimelidine. | Approved |
| Fluticasone furoate | The serum concentration of Fluticasone furoate can be increased when it is combined with Zimelidine. | Approved |
| Fluticasone propionate | The risk or severity of adverse effects can be increased when Fluticasone Propionate is combined with Zimelidine. | Approved |
| Fluvoxamine | Fluvoxamine may increase the serotonergic activities of Zimelidine. | Approved, Investigational |
| Fosphenytoin | The risk or severity of adverse effects can be increased when Fosphenytoin is combined with Zimelidine. | Approved |
| Fospropofol | The risk or severity of adverse effects can be increased when Fospropofol is combined with Zimelidine. | Approved, Illicit |
| Furazolidone | Furazolidone may increase the serotonergic activities of Zimelidine. | Approved, Vet Approved |
| Gabapentin | The risk or severity of adverse effects can be increased when Gabapentin is combined with Zimelidine. | Approved, Investigational |
| Gabapentin Enacarbil | The risk or severity of adverse effects can be increased when gabapentin enacarbil is combined with Zimelidine. | Approved |
| Galantamine | The metabolism of Galantamine can be decreased when combined with Zimelidine. | Approved |
| Gamma Hydroxybutyric Acid | The risk or severity of adverse effects can be increased when Gamma Hydroxybutyric Acid is combined with Zimelidine. | Approved, Illicit |
| Gefitinib | The serum concentration of Gefitinib can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Gemcitabine | The serum concentration of Gemcitabine can be increased when it is combined with Zimelidine. | Approved |
| Gepirone | The risk or severity of adverse effects can be increased when Gepirone is combined with Zimelidine. | Investigational |
| Gliclazide | Zimelidine may increase the hypoglycemic activities of Gliclazide. | Approved |
| Glimepiride | Zimelidine may increase the hypoglycemic activities of Glimepiride. | Approved |
| Glipizide | Zimelidine may increase the hypoglycemic activities of Glipizide. | Approved |
| Glutethimide | The risk or severity of adverse effects can be increased when Glutethimide is combined with Zimelidine. | Approved, Illicit |
| Glyburide | Zimelidine may increase the hypoglycemic activities of Glyburide. | Approved |
| Grazoprevir | The serum concentration of Grazoprevir can be increased when it is combined with Zimelidine. | Approved |
| Grepafloxacin | The serum concentration of Grepafloxacin can be increased when it is combined with Zimelidine. | Withdrawn |
| Guanfacine | The risk or severity of adverse effects can be increased when Guanfacine is combined with Zimelidine. | Approved, Investigational |
| Halazepam | The risk or severity of adverse effects can be increased when Halazepam is combined with Zimelidine. | Approved, Illicit, Withdrawn |
| Haloperidol | The serum concentration of Haloperidol can be increased when it is combined with Zimelidine. | Approved |
| Halothane | The risk or severity of adverse effects can be increased when Halothane is combined with Zimelidine. | Approved, Vet Approved |
| Heroin | Heroin may increase the serotonergic activities of Zimelidine. | Approved, Illicit |
| Hexobarbital | The risk or severity of adverse effects can be increased when Hexobarbital is combined with Zimelidine. | Approved |
| Hydracarbazine | Hydracarbazine may increase the serotonergic activities of Zimelidine. | Experimental |
| Hydrochlorothiazide | Zimelidine may increase the hyponatremic activities of Hydrochlorothiazide. | Approved, Vet Approved |
| Hydrocodone | Hydrocodone may increase the serotonergic activities of Zimelidine. | Approved, Illicit |
| Hydrocortisone | The serum concentration of Hydrocortisone can be increased when it is combined with Zimelidine. | Approved, Vet Approved |
| Hydroflumethiazide | Zimelidine may increase the hyponatremic activities of Hydroflumethiazide. | Approved |
| Hydromorphone | Hydromorphone may increase the serotonergic activities of Zimelidine. | Approved, Illicit |
| Hydroxyzine | The risk or severity of adverse effects can be increased when Hydroxyzine is combined with Zimelidine. | Approved |
| Ibuprofen | The serum concentration of Ibuprofen can be increased when it is combined with Zimelidine. | Approved |
| Idelalisib | The serum concentration of Idelalisib can be increased when it is combined with Zimelidine. | Approved |
| Iloperidone | The risk or severity of adverse effects can be increased when Iloperidone is combined with Zimelidine. | Approved |
| Imatinib | The serum concentration of Imatinib can be increased when it is combined with Zimelidine. | Approved |
| Imipramine | The serum concentration of Imipramine can be increased when it is combined with Zimelidine. | Approved |
| Indacaterol | The serum concentration of Indacaterol can be increased when it is combined with Zimelidine. | Approved |
| Indalpine | Indalpine may increase the serotonergic activities of Zimelidine. | Investigational, Withdrawn |
| Indapamide | Zimelidine may increase the hyponatremic activities of Indapamide. | Approved |
| Indenolol | The serum concentration of Indenolol can be increased when it is combined with Zimelidine. | Withdrawn |
| Indinavir | The serum concentration of Indinavir can be increased when it is combined with Zimelidine. | Approved |
| Indomethacin | The serum concentration of Indomethacin can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Insulin Aspart | Zimelidine may increase the hypoglycemic activities of Insulin Aspart. | Approved |
| Insulin Detemir | Zimelidine may increase the hypoglycemic activities of Insulin Detemir. | Approved |
| Insulin Glargine | Zimelidine may increase the hypoglycemic activities of Insulin Glargine. | Approved |
| Insulin Glulisine | Zimelidine may increase the hypoglycemic activities of Insulin Glulisine. | Approved |
| Insulin Human | Zimelidine may increase the hypoglycemic activities of Insulin Human. | Approved, Investigational |
| Insulin Lispro | Zimelidine may increase the hypoglycemic activities of Insulin Lispro. | Approved |
| Iobenguane | The therapeutic efficacy of Iobenguane can be decreased when used in combination with Zimelidine. | Approved |
| Ioflupane I-123 | Zimelidine may decrease effectiveness of Ioflupane I-123 as a diagnostic agent. | Approved |
| Iproclozide | Iproclozide may increase the serotonergic activities of Zimelidine. | Withdrawn |
| Iproniazid | Iproniazid may increase the serotonergic activities of Zimelidine. | Withdrawn |
| Irinotecan | The serum concentration of Irinotecan can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Isocarboxazid | Isocarboxazid may increase the serotonergic activities of Zimelidine. | Approved |
| Isoflurane | The risk or severity of adverse effects can be increased when Isoflurane is combined with Zimelidine. | Approved, Vet Approved |
| Ivermectin | The serum concentration of Ivermectin can be increased when it is combined with Zimelidine. | Approved, Vet Approved |
| Ketamine | The risk or severity of adverse effects can be increased when Ketamine is combined with Zimelidine. | Approved, Vet Approved |
| Ketazolam | The serum concentration of Ketazolam can be increased when it is combined with Zimelidine. | Approved |
| Ketobemidone | Ketobemidone may increase the serotonergic activities of Zimelidine. | Approved |
| Ketoconazole | The serum concentration of Ketoconazole can be increased when it is combined with Zimelidine. | Approved, Investigational |
| L-Tryptophan | L-Tryptophan may increase the serotonergic activities of Zimelidine. | Approved, Nutraceutical, Withdrawn |
| Labetalol | The serum concentration of Labetalol can be increased when it is combined with Zimelidine. | Approved |
| Lamivudine | The serum concentration of Lamivudine can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Lamotrigine | The serum concentration of Lamotrigine can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Landiolol | The serum concentration of Aop200704 can be increased when it is combined with Zimelidine. | Investigational |
| Lanreotide | Zimelidine may increase the hypoglycemic activities of Lanreotide. | Approved |
| Lansoprazole | The serum concentration of Lansoprazole can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Ledipasvir | The serum concentration of Ledipasvir can be increased when it is combined with Zimelidine. | Approved |
| Lenalidomide | The serum concentration of Lenalidomide can be increased when it is combined with Zimelidine. | Approved |
| Lenvatinib | The serum concentration of Lenvatinib can be increased when it is combined with Zimelidine. | Approved |
| Levetiracetam | The serum concentration of Levetiracetam can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Levobunolol | The serum concentration of Levobunolol can be increased when it is combined with Zimelidine. | Approved |
| Levobupivacaine | The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Zimelidine. | Approved |
| Levocabastine | The risk or severity of adverse effects can be increased when Levocabastine is combined with Zimelidine. | Approved |
| Levocetirizine | The risk or severity of adverse effects can be increased when Levocetirizine is combined with Zimelidine. | Approved |
| Levodopa | The risk or severity of adverse effects can be increased when Levodopa is combined with Zimelidine. | Approved |
| Levofloxacin | The serum concentration of Levofloxacin can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Levomethadyl Acetate | Levomethadyl Acetate may increase the serotonergic activities of Zimelidine. | Approved |
| Levomilnacipran | Levomilnacipran may increase the serotonergic activities of Zimelidine. | Approved |
| Levorphanol | Levorphanol may increase the serotonergic activities of Zimelidine. | Approved |
| Levothyroxine | The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Zimelidine. | Approved |
| Lidocaine | The risk or severity of adverse effects can be increased when Lidocaine is combined with Zimelidine. | Approved, Vet Approved |
| Linagliptin | The serum concentration of Linagliptin can be increased when it is combined with Zimelidine. | Approved |
| Linezolid | Linezolid may increase the serotonergic activities of Zimelidine. | Approved, Investigational |
| Liothyronine | The therapeutic efficacy of Liothyronine can be decreased when used in combination with Zimelidine. | Approved, Vet Approved |
| Liotrix | The therapeutic efficacy of Liotrix can be decreased when used in combination with Zimelidine. | Approved |
| Liraglutide | Zimelidine may increase the hypoglycemic activities of Liraglutide. | Approved |
| Lithium | Lithium may increase the serotonergic activities of Zimelidine. | Approved |
| Lofentanil | Lofentanil may increase the serotonergic activities of Zimelidine. | Illicit |
| Loperamide | The serum concentration of Loperamide can be increased when it is combined with Zimelidine. | Approved |
| Loratadine | The risk or severity of adverse effects can be increased when Loratadine is combined with Zimelidine. | Approved |
| Lorazepam | The risk or severity of adverse effects can be increased when Lorazepam is combined with Zimelidine. | Approved |
| Losartan | The serum concentration of Losartan can be increased when it is combined with Zimelidine. | Approved |
| Loxapine | The risk or severity of adverse effects can be increased when Loxapine is combined with Zimelidine. | Approved |
| Lumiracoxib | Zimelidine may increase the antiplatelet activities of Lumiracoxib. | Approved, Investigational |
| Lurasidone | The risk or severity of adverse effects can be increased when Lurasidone is combined with Zimelidine. | Approved |
| Magnesium Sulfate | The risk or severity of adverse effects can be increased when Magnesium Sulfate is combined with Zimelidine. | Approved, Vet Approved |
| Mannitol | The serum concentration of Mannitol can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Maprotiline | The risk or severity of adverse effects can be increased when Maprotiline is combined with Zimelidine. | Approved |
| Mebanazine | Mebanazine may increase the serotonergic activities of Zimelidine. | Withdrawn |
| Mecasermin | Zimelidine may increase the hypoglycemic activities of Mecasermin. | Approved, Investigational |
| Meclizine | The risk or severity of adverse effects can be increased when Meclizine is combined with Zimelidine. | Approved |
| Melatonin | The risk or severity of adverse effects can be increased when Melatonin is combined with Zimelidine. | Approved, Nutraceutical, Vet Approved |
| Melperone | The risk or severity of adverse effects can be increased when Melperone is combined with Zimelidine. | Approved |
| Mepivacaine | The risk or severity of adverse effects can be increased when Mepivacaine is combined with Zimelidine. | Approved, Vet Approved |
| Meprobamate | The risk or severity of adverse effects can be increased when Meprobamate is combined with Zimelidine. | Approved, Illicit |
| Mesoridazine | The risk or severity of adverse effects can be increased when Mesoridazine is combined with Zimelidine. | Approved |
| Metaxalone | The risk or severity of adverse effects can be increased when Metaxalone is combined with Zimelidine. | Approved |
| Metformin | Zimelidine may increase the hypoglycemic activities of Metformin. | Approved |
| Methadone | The metabolism of Methadone can be decreased when combined with Zimelidine. | Approved |
| Methadyl Acetate | Methadyl Acetate may increase the serotonergic activities of Zimelidine. | Approved, Illicit |
| Methapyrilene | The risk or severity of adverse effects can be increased when Methapyrilene is combined with Zimelidine. | Withdrawn |
| Methaqualone | The risk or severity of adverse effects can be increased when Methaqualone is combined with Zimelidine. | Illicit, Withdrawn |
| Methocarbamol | The risk or severity of adverse effects can be increased when Methocarbamol is combined with Zimelidine. | Approved, Vet Approved |
| Methohexital | The risk or severity of adverse effects can be increased when Methohexital is combined with Zimelidine. | Approved |
| Methotrexate | The serum concentration of Methotrexate can be increased when it is combined with Zimelidine. | Approved |
| Methotrimeprazine | The risk or severity of adverse effects can be increased when Methotrimeprazine is combined with Zimelidine. | Approved |
| Methoxyflurane | The risk or severity of adverse effects can be increased when Methoxyflurane is combined with Zimelidine. | Approved, Vet Approved |
| Methsuximide | The risk or severity of adverse effects can be increased when Methsuximide is combined with Zimelidine. | Approved |
| Methyclothiazide | Zimelidine may increase the hyponatremic activities of Methyclothiazide. | Approved |
| Methylecgonine | The risk or severity of adverse effects can be increased when ECGONINE METHYL ESTER is combined with Zimelidine. | Experimental |
| Methylene blue | Zimelidine may increase the serotonergic activities of Methylene blue. | Investigational |
| Methylphenobarbital | The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Zimelidine. | Approved |
| Methylprednisolone | The serum concentration of Methylprednisolone can be increased when it is combined with Zimelidine. | Approved, Vet Approved |
| Metipranolol | The serum concentration of Metipranolol can be increased when it is combined with Zimelidine. | Approved |
| Metoclopramide | The risk or severity of adverse effects can be increased when Metoclopramide is combined with Zimelidine. | Approved, Investigational |
| Metolazone | Zimelidine may increase the hyponatremic activities of Metolazone. | Approved |
| Metoprolol | The serum concentration of Metoprolol can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Metyrosine | The risk or severity of adverse effects can be increased when Metyrosine is combined with Zimelidine. | Approved |
| Mexiletine | The metabolism of Mexiletine can be decreased when combined with Zimelidine. | Approved |
| Midazolam | The serum concentration of Midazolam can be increased when it is combined with Zimelidine. | Approved, Illicit |
| Mifepristone | Zimelidine may increase the hypoglycemic activities of Mifepristone. | Approved, Investigational |
| Miglitol | Zimelidine may increase the hypoglycemic activities of Miglitol. | Approved |
| Milnacipran | Milnacipran may increase the serotonergic activities of Zimelidine. | Approved |
| Minaprine | Minaprine may increase the serotonergic activities of Zimelidine. | Approved |
| Mirabegron | The serum concentration of Mirabegron can be increased when it is combined with Zimelidine. | Approved |
| Mirtazapine | The risk or severity of adverse effects can be increased when Mirtazapine is combined with Zimelidine. | Approved |
| Mitoxantrone | The serum concentration of Mitoxantrone can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Moclobemide | Moclobemide may increase the serotonergic activities of Zimelidine. | Approved |
| Molindone | The risk or severity of adverse effects can be increased when Molindone is combined with Zimelidine. | Approved |
| Moricizine | The risk or severity of adverse effects can be increased when Moricizine is combined with Zimelidine. | Approved, Withdrawn |
| Morphine | The serum concentration of Morphine can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Mycophenolate mofetil | The serum concentration of Mycophenolate mofetil can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Nabilone | The risk or severity of adverse effects can be increased when Nabilone is combined with Zimelidine. | Approved, Investigational |
| Nabumetone | Zimelidine may increase the antiplatelet activities of Nabumetone. | Approved |
| Nadolol | The serum concentration of Nadolol can be increased when it is combined with Zimelidine. | Approved |
| Nalbuphine | Nalbuphine may increase the serotonergic activities of Zimelidine. | Approved |
| Naloxegol | The serum concentration of Naloxegol can be increased when it is combined with Zimelidine. | Approved |
| Naloxone | The serum concentration of Naloxone can be increased when it is combined with Zimelidine. | Approved, Vet Approved |
| Nateglinide | Zimelidine may increase the hypoglycemic activities of Nateglinide. | Approved, Investigational |
| Nefazodone | Nefazodone may increase the serotonergic activities of Zimelidine. | Approved, Withdrawn |
| Nelfinavir | The serum concentration of Nelfinavir can be increased when it is combined with Zimelidine. | Approved |
| Nialamide | Nialamide may increase the serotonergic activities of Zimelidine. | Withdrawn |
| Nicardipine | The serum concentration of Nicardipine can be increased when it is combined with Zimelidine. | Approved |
| Nifedipine | The serum concentration of Nifedipine can be increased when it is combined with Zimelidine. | Approved |
| Nilotinib | The serum concentration of Nilotinib can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Nintedanib | The serum concentration of Nintedanib can be increased when it is combined with Zimelidine. | Approved |
| Nitrazepam | The risk or severity of adverse effects can be increased when Nitrazepam is combined with Zimelidine. | Approved |
| Nitrous oxide | The risk or severity of adverse effects can be increased when Nitrous oxide is combined with Zimelidine. | Approved, Vet Approved |
| Nizatidine | The serum concentration of Nizatidine can be increased when it is combined with Zimelidine. | Approved |
| Norflurane | The risk or severity of adverse effects can be increased when 1,1,1,2 Tetrafluoroethane is combined with Zimelidine. | Investigational |
| Normethadone | Normethadone may increase the serotonergic activities of Zimelidine. | Approved, Illicit |
| Nortriptyline | The risk or severity of adverse effects can be increased when Nortriptyline is combined with Zimelidine. | Approved |
| Octamoxin | Octamoxin may increase the serotonergic activities of Zimelidine. | Withdrawn |
| Octreotide | Zimelidine may increase the hypoglycemic activities of Octreotide. | Approved, Investigational |
| Olanzapine | Zimelidine may increase the serotonergic activities of Olanzapine. | Approved, Investigational |
| Olopatadine | The risk or severity of adverse effects can be increased when Olopatadine is combined with Zimelidine. | Approved |
| Ombitasvir | The serum concentration of Ombitasvir can be increased when it is combined with Zimelidine. | Approved |
| Ondansetron | The risk or severity of adverse effects can be increased when Ondansetron is combined with Zimelidine. | Approved |
| Opium | Opium may increase the serotonergic activities of Zimelidine. | Approved, Illicit |
| Orphenadrine | The risk or severity of adverse effects can be increased when Orphenadrine is combined with Zimelidine. | Approved |
| Osanetant | The risk or severity of adverse effects can be increased when Osanetant is combined with Zimelidine. | Investigational |
| Osimertinib | The serum concentration of Osimertinib can be increased when it is combined with Zimelidine. | Approved |
| Oxazepam | The risk or severity of adverse effects can be increased when Oxazepam is combined with Zimelidine. | Approved |
| Oxethazaine | The risk or severity of adverse effects can be increased when Oxetacaine is combined with Zimelidine. | Investigational |
| Oxprenolol | The serum concentration of Oxprenolol can be increased when it is combined with Zimelidine. | Approved |
| Oxybuprocaine | The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Zimelidine. | Approved |
| Oxycodone | Oxycodone may increase the serotonergic activities of Zimelidine. | Approved, Illicit, Investigational |
| Oxymorphone | Oxymorphone may increase the serotonergic activities of Zimelidine. | Approved, Investigational, Vet Approved |
| Paclitaxel | The serum concentration of Paclitaxel can be increased when it is combined with Zimelidine. | Approved, Vet Approved |
| Paliperidone | The risk or severity of adverse effects can be increased when Paliperidone is combined with Zimelidine. | Approved |
| Panobinostat | The serum concentration of Panobinostat can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Paraldehyde | The risk or severity of adverse effects can be increased when Paraldehyde is combined with Zimelidine. | Approved |
| Parecoxib | Zimelidine may increase the antiplatelet activities of Parecoxib. | Approved |
| Pargyline | Pargyline may increase the serotonergic activities of Zimelidine. | Approved |
| Paroxetine | Paroxetine may increase the serotonergic activities of Zimelidine. | Approved, Investigational |
| Pasireotide | Zimelidine may increase the hypoglycemic activities of Pasireotide. | Approved |
| Pazopanib | The serum concentration of Pazopanib can be increased when it is combined with Zimelidine. | Approved |
| Penbutolol | The serum concentration of Penbutolol can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Pentamidine | Zimelidine may increase the hypoglycemic activities of Pentamidine. | Approved |
| Pentazocine | Pentazocine may increase the serotonergic activities of Zimelidine. | Approved, Vet Approved |
| Pentobarbital | The risk or severity of adverse effects can be increased when Pentobarbital is combined with Zimelidine. | Approved, Vet Approved |
| Perampanel | The risk or severity of adverse effects can be increased when Perampanel is combined with Zimelidine. | Approved |
| Perazine | The risk or severity of adverse effects can be increased when Perazine is combined with Zimelidine. | Investigational |
| Perospirone | The risk or severity of adverse effects can be increased when Perospirone is combined with Zimelidine. | Approved |
| Perphenazine | The risk or severity of adverse effects can be increased when Perphenazine is combined with Zimelidine. | Approved |
| Pethidine | Pethidine may increase the serotonergic activities of Zimelidine. | Approved |
| Phenelzine | Phenelzine may increase the serotonergic activities of Zimelidine. | Approved |
| Phenindione | Zimelidine may increase the anticoagulant activities of Phenindione. | Approved |
| Pheniprazine | Pheniprazine may increase the serotonergic activities of Zimelidine. | Withdrawn |
| Phenobarbital | The serum concentration of Phenobarbital can be increased when it is combined with Zimelidine. | Approved |
| Phenoxypropazine | Phenoxypropazine may increase the serotonergic activities of Zimelidine. | Withdrawn |
| Phenprocoumon | Zimelidine may increase the anticoagulant activities of Phenprocoumon. | Approved |
| Phenytoin | The serum concentration of Phenytoin can be increased when it is combined with Zimelidine. | Approved, Vet Approved |
| Pimozide | The risk or severity of adverse effects can be increased when Zimelidine is combined with Pimozide. | Approved |
| Pindolol | The serum concentration of Pindolol can be increased when it is combined with Zimelidine. | Approved |
| Pioglitazone | Zimelidine may increase the hypoglycemic activities of Pioglitazone. | Approved, Investigational |
| Pipamperone | The risk or severity of adverse effects can be increased when Pipamperone is combined with Zimelidine. | Approved |
| Pipotiazine | The risk or severity of adverse effects can be increased when Pipotiazine is combined with Zimelidine. | Approved |
| Piritramide | Piritramide may increase the serotonergic activities of Zimelidine. | Investigational |
| Pirlindole | Pirlindole may increase the serotonergic activities of Zimelidine. | Approved |
| Pitavastatin | The serum concentration of Pitavastatin can be increased when it is combined with Zimelidine. | Approved |
| Pivhydrazine | Pivhydrazine may increase the serotonergic activities of Zimelidine. | Withdrawn |
| Polythiazide | Zimelidine may increase the hyponatremic activities of Polythiazide. | Approved |
| Pomalidomide | The serum concentration of Pomalidomide can be increased when it is combined with Zimelidine. | Approved |
| Ponatinib | The serum concentration of Ponatinib can be increased when it is combined with Zimelidine. | Approved |
| Practolol | The serum concentration of Practolol can be increased when it is combined with Zimelidine. | Approved |
| Pramlintide | Zimelidine may increase the hypoglycemic activities of Pramlintide. | Approved, Investigational |
| Pramocaine | The risk or severity of adverse effects can be increased when Pramocaine is combined with Zimelidine. | Approved |
| Pravastatin | The serum concentration of Pravastatin can be increased when it is combined with Zimelidine. | Approved |
| Prazepam | The risk or severity of adverse effects can be increased when Prazepam is combined with Zimelidine. | Approved, Illicit |
| Prazosin | The serum concentration of Prazosin can be increased when it is combined with Zimelidine. | Approved |
| Prednisolone | The serum concentration of Prednisolone can be increased when it is combined with Zimelidine. | Approved, Vet Approved |
| Prednisone | The serum concentration of Prednisone can be increased when it is combined with Zimelidine. | Approved, Vet Approved |
| Pregabalin | The risk or severity of adverse effects can be increased when Pregabalin is combined with Zimelidine. | Approved, Illicit, Investigational |
| Prilocaine | The risk or severity of adverse effects can be increased when Prilocaine is combined with Zimelidine. | Approved |
| Primidone | The risk or severity of adverse effects can be increased when Primidone is combined with Zimelidine. | Approved, Vet Approved |
| Procaine | The risk or severity of adverse effects can be increased when Procaine is combined with Zimelidine. | Approved, Investigational, Vet Approved |
| Prochlorperazine | The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Zimelidine. | Approved, Vet Approved |
| Progesterone | The serum concentration of Progesterone can be increased when it is combined with Zimelidine. | Approved, Vet Approved |
| Promazine | The risk or severity of adverse effects can be increased when Promazine is combined with Zimelidine. | Approved, Vet Approved |
| Promethazine | The risk or severity of adverse effects can be increased when Promethazine is combined with Zimelidine. | Approved |
| Proparacaine | The risk or severity of adverse effects can be increased when Proparacaine is combined with Zimelidine. | Approved, Vet Approved |
| Propofol | The risk or severity of adverse effects can be increased when Propofol is combined with Zimelidine. | Approved, Investigational, Vet Approved |
| Propoxycaine | The risk or severity of adverse effects can be increased when Propoxycaine is combined with Zimelidine. | Approved |
| Propranolol | The serum concentration of Propranolol can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Protriptyline | The risk or severity of adverse effects can be increased when Protriptyline is combined with Zimelidine. | Approved |
| Prucalopride | The serum concentration of Prucalopride can be increased when it is combined with Zimelidine. | Approved |
| Quazepam | The risk or severity of adverse effects can be increased when Quazepam is combined with Zimelidine. | Approved, Illicit |
| Quetiapine | The serum concentration of Quetiapine can be increased when it is combined with Zimelidine. | Approved |
| Quinethazone | Zimelidine may increase the hyponatremic activities of Quinethazone. | Approved |
| Quinidine | The serum concentration of Quinidine can be increased when it is combined with Zimelidine. | Approved |
| Quinine | The serum concentration of Quinine can be increased when it is combined with Zimelidine. | Approved |
| Raclopride | The risk or severity of adverse effects can be increased when Raclopride is combined with Zimelidine. | Investigational |
| Ramelteon | The risk or severity of adverse effects can be increased when Ramelteon is combined with Zimelidine. | Approved, Investigational |
| Ranitidine | The serum concentration of Ranitidine can be increased when it is combined with Zimelidine. | Approved |
| Ranolazine | The serum concentration of Ranolazine can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Rasagiline | Rasagiline may increase the serotonergic activities of Zimelidine. | Approved |
| Remifentanil | Remifentanil may increase the serotonergic activities of Zimelidine. | Approved |
| Remoxipride | The risk or severity of adverse effects can be increased when Remoxipride is combined with Zimelidine. | Approved, Withdrawn |
| Repaglinide | Zimelidine may increase the hypoglycemic activities of Repaglinide. | Approved, Investigational |
| Reserpine | The serum concentration of Reserpine can be increased when it is combined with Zimelidine. | Approved |
| Rifampicin | The serum concentration of Rifampicin can be increased when it is combined with Zimelidine. | Approved |
| Rifaximin | The serum concentration of Rifaximin can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Risperidone | The metabolism of Risperidone can be decreased when combined with Zimelidine. | Approved, Investigational |
| Ritanserin | The risk or severity of adverse effects can be increased when Ritanserin is combined with Zimelidine. | Investigational |
| Ritonavir | The serum concentration of Ritonavir can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Rivaroxaban | The serum concentration of Rivaroxaban can be increased when it is combined with Zimelidine. | Approved |
| Rofecoxib | Zimelidine may increase the antiplatelet activities of Rofecoxib. | Investigational, Withdrawn |
| Romidepsin | The serum concentration of Romidepsin can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Ropivacaine | The risk or severity of adverse effects can be increased when Ropivacaine is combined with Zimelidine. | Approved |
| Rosiglitazone | Zimelidine may increase the hypoglycemic activities of Rosiglitazone. | Approved, Investigational |
| Safrazine | Safrazine may increase the serotonergic activities of Zimelidine. | Withdrawn |
| Salicylic acid | The serum concentration of Salicylic acid can be increased when it is combined with Zimelidine. | Approved, Vet Approved |
| Saquinavir | The serum concentration of Saquinavir can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Saxagliptin | Zimelidine may increase the hypoglycemic activities of Saxagliptin. | Approved |
| Scopolamine | The risk or severity of adverse effects can be increased when Scopolamine is combined with Zimelidine. | Approved |
| Secobarbital | The risk or severity of adverse effects can be increased when Secobarbital is combined with Zimelidine. | Approved, Vet Approved |
| Selegiline | Selegiline may increase the serotonergic activities of Zimelidine. | Approved, Investigational, Vet Approved |
| Selexipag | The serum concentration of Selexipag can be increased when it is combined with Zimelidine. | Approved |
| Sepranolone | The risk or severity of adverse effects can be increased when Uc1010 is combined with Zimelidine. | Investigational |
| Sertindole | The risk or severity of adverse effects can be increased when Sertindole is combined with Zimelidine. | Approved, Withdrawn |
| Sertraline | Sertraline may increase the serotonergic activities of Zimelidine. | Approved |
| Sevoflurane | The risk or severity of adverse effects can be increased when Sevoflurane is combined with Zimelidine. | Approved, Vet Approved |
| Silodosin | The serum concentration of Silodosin can be increased when it is combined with Zimelidine. | Approved |
| Simeprevir | The serum concentration of Simeprevir can be increased when it is combined with Zimelidine. | Approved |
| Sitagliptin | The serum concentration of Sitagliptin can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Sodium oxybate | The risk or severity of adverse effects can be increased when Sodium oxybate is combined with Zimelidine. | Approved |
| Sofosbuvir | The serum concentration of Sofosbuvir can be increased when it is combined with Zimelidine. | Approved |
| Sorafenib | The serum concentration of Sorafenib can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Sotalol | The serum concentration of Sotalol can be increased when it is combined with Zimelidine. | Approved |
| Sparfloxacin | The serum concentration of Sparfloxacin can be increased when it is combined with Zimelidine. | Approved |
| Sphingosine | The serum concentration of Sphingosine can be increased when it is combined with Zimelidine. | Experimental |
| Stiripentol | The risk or severity of adverse effects can be increased when Stiripentol is combined with Zimelidine. | Approved |
| Sufentanil | Sufentanil may increase the serotonergic activities of Zimelidine. | Approved, Investigational |
| Sulfadiazine | Zimelidine may increase the hypoglycemic activities of Sulfadiazine. | Approved, Vet Approved |
| Sulfamethoxazole | Zimelidine may increase the hypoglycemic activities of Sulfamethoxazole. | Approved |
| Sulfisoxazole | Zimelidine may increase the hypoglycemic activities of Sulfisoxazole. | Approved, Vet Approved |
| Sulpiride | The risk or severity of adverse effects can be increased when Sulpiride is combined with Zimelidine. | Approved |
| Sunitinib | Zimelidine may increase the hypoglycemic activities of Sunitinib. | Approved, Investigational |
| Suvorexant | The risk or severity of adverse effects can be increased when Suvorexant is combined with Zimelidine. | Approved |
| Tacrolimus | The metabolism of Tacrolimus can be decreased when combined with Zimelidine. | Approved, Investigational |
| Tacrolimus | The serum concentration of Tacrolimus can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Tamoxifen | The serum concentration of Tamoxifen can be increased when it is combined with Zimelidine. | Approved |
| Tandospirone | The risk or severity of adverse effects can be increased when Tandospirone is combined with Zimelidine. | Investigational |
| Tapentadol | Tapentadol may increase the serotonergic activities of Zimelidine. | Approved |
| Tasimelteon | The risk or severity of adverse effects can be increased when Tasimelteon is combined with Zimelidine. | Approved |
| Taurocholic Acid | The serum concentration of Taurocholic Acid can be increased when it is combined with Zimelidine. | Experimental |
| Technetium Tc-99m sestamibi | The serum concentration of Technetium Tc-99m sestamibi can be increased when it is combined with Zimelidine. | Approved |
| Telaprevir | The serum concentration of Telaprevir can be increased when it is combined with Zimelidine. | Withdrawn |
| Temazepam | The risk or severity of adverse effects can be increased when Temazepam is combined with Zimelidine. | Approved |
| Temsirolimus | The serum concentration of Temsirolimus can be increased when it is combined with Zimelidine. | Approved |
| Tetrabenazine | The risk or severity of adverse effects can be increased when Tetrabenazine is combined with Zimelidine. | Approved |
| Tetracaine | The risk or severity of adverse effects can be increased when Tetracaine is combined with Zimelidine. | Approved, Vet Approved |
| Tetrodotoxin | The risk or severity of adverse effects can be increased when Tetrodotoxin is combined with Zimelidine. | Investigational |
| Thalidomide | The risk or severity of adverse effects can be increased when Thalidomide is combined with Zimelidine. | Approved, Investigational, Withdrawn |
| Thiamylal | The risk or severity of adverse effects can be increased when Thiamylal is combined with Zimelidine. | Approved, Vet Approved |
| Thiethylperazine | The risk or severity of adverse effects can be increased when Thiethylperazine is combined with Zimelidine. | Withdrawn |
| Thiopental | The risk or severity of adverse effects can be increased when Thiopental is combined with Zimelidine. | Approved, Vet Approved |
| Thioridazine | The risk or severity of adverse effects can be increased when Thioridazine is combined with Zimelidine. | Withdrawn |
| Thiothixene | The risk or severity of adverse effects can be increased when Thiothixene is combined with Zimelidine. | Approved |
| Thyroid, porcine | The therapeutic efficacy of Thyroid, porcine can be decreased when used in combination with Zimelidine. | Approved |
| Tiagabine | The risk or severity of adverse effects can be increased when Tiagabine is combined with Zimelidine. | Approved |
| Tiapride | The risk or severity of adverse effects can be increased when Tiapride is combined with Zimelidine. | Approved, Investigational |
| Ticagrelor | The serum concentration of Ticagrelor can be increased when it is combined with Zimelidine. | Approved |
| Timolol | The serum concentration of Timolol can be increased when it is combined with Zimelidine. | Approved |
| Tizanidine | The risk or severity of adverse effects can be increased when Tizanidine is combined with Zimelidine. | Approved |
| Tolazamide | Zimelidine may increase the hypoglycemic activities of Tolazamide. | Approved |
| Tolbutamide | Zimelidine may increase the hypoglycemic activities of Tolbutamide. | Approved |
| Tolcapone | The risk or severity of adverse effects can be increased when Tolcapone is combined with Zimelidine. | Approved, Withdrawn |
| Toloxatone | Toloxatone may increase the serotonergic activities of Zimelidine. | Approved |
| Tolvaptan | The serum concentration of Tolvaptan can be increased when it is combined with Zimelidine. | Approved |
| Topiramate | The risk or severity of adverse effects can be increased when Topiramate is combined with Zimelidine. | Approved |
| Topotecan | The serum concentration of Topotecan can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Toremifene | The serum concentration of Toremifene can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Tramadol | Zimelidine may increase the neuroexcitatory activities of Tramadol. | Approved, Investigational |
| Trans-2-Phenylcyclopropylamine | Trans-2-Phenylcyclopropylamine may increase the serotonergic activities of Zimelidine. | Experimental |
| Tranylcypromine | Tranylcypromine may increase the serotonergic activities of Zimelidine. | Approved |
| Trastuzumab emtansine | The serum concentration of Trastuzumab emtansine can be increased when it is combined with Zimelidine. | Approved |
| Trazodone | Zimelidine may increase the serotonergic activities of Trazodone. | Approved, Investigational |
| Triazolam | The risk or severity of adverse effects can be increased when Triazolam is combined with Zimelidine. | Approved |
| Trichlormethiazide | Zimelidine may increase the hyponatremic activities of Trichlormethiazide. | Approved, Vet Approved |
| Trifluoperazine | The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Zimelidine. | Approved |
| Triflupromazine | The risk or severity of adverse effects can be increased when Triflupromazine is combined with Zimelidine. | Approved, Vet Approved |
| Trimipramine | The risk or severity of adverse effects can be increased when Trimipramine is combined with Zimelidine. | Approved |
| Triprolidine | The risk or severity of adverse effects can be increased when Triprolidine is combined with Zimelidine. | Approved |
| Ulipristal | The serum concentration of Ulipristal can be increased when it is combined with Zimelidine. | Approved |
| Umeclidinium | The serum concentration of Umeclidinium can be increased when it is combined with Zimelidine. | Approved |
| Valdecoxib | Zimelidine may increase the antiplatelet activities of Valdecoxib. | Investigational, Withdrawn |
| Valproic Acid | The risk or severity of adverse effects can be increased when Valproic Acid is combined with Zimelidine. | Approved, Investigational |
| Vecuronium | The serum concentration of Vecuronium can be increased when it is combined with Zimelidine. | Approved |
| Venetoclax | The serum concentration of Venetoclax can be increased when it is combined with Zimelidine. | Approved |
| Venlafaxine | Venlafaxine may increase the serotonergic activities of Zimelidine. | Approved |
| Verapamil | The serum concentration of Verapamil can be increased when it is combined with Zimelidine. | Approved |
| Vigabatrin | The risk or severity of adverse effects can be increased when Vigabatrin is combined with Zimelidine. | Approved |
| Vilazodone | Zimelidine may increase the serotonergic activities of Vilazodone. | Approved |
| Vinblastine | The serum concentration of Vinblastine can be increased when it is combined with Zimelidine. | Approved |
| Vincristine | The serum concentration of Vincristine can be increased when it is combined with Zimelidine. | Approved, Investigational |
| Vismodegib | The serum concentration of Vismodegib can be increased when it is combined with Zimelidine. | Approved |
| Vortioxetine | Zimelidine may increase the serotonergic activities of Vortioxetine. | Approved |
| Warfarin | Zimelidine may increase the anticoagulant activities of Warfarin. | Approved |
| Zaleplon | The risk or severity of adverse effects can be increased when Zaleplon is combined with Zimelidine. | Approved, Illicit, Investigational |
| Ziconotide | The risk or severity of adverse effects can be increased when Ziconotide is combined with Zimelidine. | Approved |
| Zidovudine | The serum concentration of Zidovudine can be increased when it is combined with Zimelidine. | Approved |
| Ziprasidone | The risk or severity of adverse effects can be increased when Ziprasidone is combined with Zimelidine. | Approved |
| Zolpidem | The risk or severity of adverse effects can be increased when Zolpidem is combined with Zimelidine. | Approved |
| Zonisamide | The risk or severity of adverse effects can be increased when Zonisamide is combined with Zimelidine. | Approved, Investigational |
| Zopiclone | The risk or severity of adverse effects can be increased when Zopiclone is combined with Zimelidine. | Approved |
| Zotepine | The risk or severity of adverse effects can be increased when Zotepine is combined with Zimelidine. | Approved |
| Zuclopenthixol | The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Zimelidine. | Approved, Investigational |
